| Dr Paul W Kempe, MD | |
|
6465 S Yale Ave Ste 910, Tulsa, OK 74136 | |
| (918) 502-3200 | |
| (918) 502-3205 |
| Full Name | Dr Paul W Kempe |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 39 Years |
| Location | 6465 S Yale Ave Ste 910, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396825345 | NPI | - | NPPES |
| 100152780A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 21308 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health Of Northeast Oklahoma | Broken arrow, OK | Home health agency |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital South, Llc | Tulsa, OK | Hospital |
| Saint Francis Hospital Muskogee | Muskogee, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warren Clinic Inc | 8820900293 | 604 |
News Archive
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
One of the most complex human organs is the digestive tract: Here, the body comes into contact with all manner of diet-derived compounds and with countless bacteria.
As the pandemic persists, COVID-19 has claimed more than 200,000 lives in the United States and damaged the public health system and economy.
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Novel use of genetic testing methods helped public health officials control and limit the further spread of four outbreaks of foodborne hepatitis A virus in 2003 related to the consumption of green onions, according to a detailed analysis published in the October 15 issue of The Journal of Infectious Diseases, now available online.
› Verified 1 days ago
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
One of the most complex human organs is the digestive tract: Here, the body comes into contact with all manner of diet-derived compounds and with countless bacteria.
As the pandemic persists, COVID-19 has claimed more than 200,000 lives in the United States and damaged the public health system and economy.
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Novel use of genetic testing methods helped public health officials control and limit the further spread of four outbreaks of foodborne hepatitis A virus in 2003 related to the consumption of green onions, according to a detailed analysis published in the October 15 issue of The Journal of Infectious Diseases, now available online.
› Verified 1 days ago
| Entity Name | St John Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336194406 PECOS PAC ID: 2567366495 Enrollment ID: O20031121000867 |
News Archive
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
One of the most complex human organs is the digestive tract: Here, the body comes into contact with all manner of diet-derived compounds and with countless bacteria.
As the pandemic persists, COVID-19 has claimed more than 200,000 lives in the United States and damaged the public health system and economy.
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Novel use of genetic testing methods helped public health officials control and limit the further spread of four outbreaks of foodborne hepatitis A virus in 2003 related to the consumption of green onions, according to a detailed analysis published in the October 15 issue of The Journal of Infectious Diseases, now available online.
› Verified 1 days ago
| Entity Name | Ahs Oklahoma Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235182775 PECOS PAC ID: 9436122496 Enrollment ID: O20040817001197 |
News Archive
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
One of the most complex human organs is the digestive tract: Here, the body comes into contact with all manner of diet-derived compounds and with countless bacteria.
As the pandemic persists, COVID-19 has claimed more than 200,000 lives in the United States and damaged the public health system and economy.
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Novel use of genetic testing methods helped public health officials control and limit the further spread of four outbreaks of foodborne hepatitis A virus in 2003 related to the consumption of green onions, according to a detailed analysis published in the October 15 issue of The Journal of Infectious Diseases, now available online.
› Verified 1 days ago
| Entity Name | Ahs Oklahoma Heart Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780857540 PECOS PAC ID: 4587737135 Enrollment ID: O20080716000032 |
News Archive
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
One of the most complex human organs is the digestive tract: Here, the body comes into contact with all manner of diet-derived compounds and with countless bacteria.
As the pandemic persists, COVID-19 has claimed more than 200,000 lives in the United States and damaged the public health system and economy.
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Novel use of genetic testing methods helped public health officials control and limit the further spread of four outbreaks of foodborne hepatitis A virus in 2003 related to the consumption of green onions, according to a detailed analysis published in the October 15 issue of The Journal of Infectious Diseases, now available online.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul W Kempe, MD 6600 S Yale Ave Ste 1200, Tulsa, OK 74136-3361 Ph: (918) 488-6045 | Dr Paul W Kempe, MD 6465 S Yale Ave Ste 910, Tulsa, OK 74136 Ph: (918) 502-3200 |
News Archive
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
One of the most complex human organs is the digestive tract: Here, the body comes into contact with all manner of diet-derived compounds and with countless bacteria.
As the pandemic persists, COVID-19 has claimed more than 200,000 lives in the United States and damaged the public health system and economy.
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Novel use of genetic testing methods helped public health officials control and limit the further spread of four outbreaks of foodborne hepatitis A virus in 2003 related to the consumption of green onions, according to a detailed analysis published in the October 15 issue of The Journal of Infectious Diseases, now available online.
› Verified 1 days ago
Robert Blankenship, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 1923 S Utica Ave, Tulsa, OK 74104 Phone: 918-712-3366 Fax: 918-403-6343 | |
Hope Cordova, D.O. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 6465 S Yale Ave Ste 910, Tulsa, OK 74136 Phone: 918-502-3200 Fax: 918-502-3205 | |
Larry J Dullye, DO Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 802 S Jackson Ave, 200, Tulsa, OK 74127 Phone: 918-585-3372 Fax: 918-599-9116 | |
John Franco A Carabello, DO Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 802 S Jackson Ave Ste 200, Tulsa, OK 74127 Phone: 918-582-7711 Fax: 918-583-5831 | |
Shane S. Yamane, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 802 S Jackson Ave Ste 225, Tulsa, OK 74127 Phone: 918-582-7711 Fax: 918-583-5831 | |
Kryston Renee Boyer, D.O. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 802 S Jackson Ave Ste 225, Tulsa, OK 74127 Phone: 918-582-7711 Fax: 918-583-5831 |